Preparation and characterization of doxorubicin-loaded sterically stabilized immunoliposomes

Pharmaceutical Research

Volumn 13, Issue 3, 1996, Pages 352-359

  Emanuel, Noam ^a   Kedar, Eli ^a   Bolotin, Elijah M ^a   Smorodinsky, Nechama I ^b   Barenholz, Yechezkel ^a  

^a HEBREW UNIVERSITY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Doxorubicin; Immunospecificity; Sterically stabilized immunoliposomes; Targeting; Tumor cells

Indexed keywords

DOXORUBICIN; IMMUNOLIPOSOME; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DRUG BINDING; DRUG DISTRIBUTION; DRUG RELEASE; DRUG STABILITY; DRUG TARGETING; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; TUMOR CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; CHEMISTRY, PHARMACEUTICAL; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FEMALE; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; LIPOSOMES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 0029937913     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016028106337     Document Type: Article

References (29)

1. M. C. Woodle and D. D. Lasic. Sterically stabilized liposomes. Biochim. Biophys. Acta 1113:171-199 (1992).
2. L. Huang, ed. Forum: Covalently attached polymers and glycans to alter the biodistribution of liposomes. J. Liposome Res. 2:289-454 (1992).
3. A. A. Gabizon, Y. Barenholz, and M. Bialer. Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: Pharmacokinetic studies in rodents and dogs. Pharm. Res. 10:703-708 (1993).
4. A. Gabizon, R. Catane, B. Uziely, B. Kaufman, T. Safra, R. Cohen, F. Martin, A. Huang, and Y. Barenholz. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res. 54:987-992 (1994).
5. D. Papahadjopoulos, T. M. Allen, A. A. Gabizon, E. Mayhew, K. Matthay, S. K. Huang, K.-D. Lee, M. C. Woodle, D. D. Lasic, C. Redemann, and F. J. Martin. Stericalty stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA 88:11460-11464 (1991).
6. A. H. Schon, Suppression of antibody responses by conjugates of antigens and monomethoxypoly(ethylene glycol). Adv. Drug Delivery Rev. 6:203-217 (1991).
7. C. Delgado, G. E. Francis, and D. Fisher. The uses and properties of PEG-linked proteins. Crit. Rev. Ther. Drug Carrier Syst. 9:249-304 (1992).
8. A. L. Klibanov, K. Maruyama, A. M. Beckerleg, V. P. Torchilin, and L. Huang. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1062:142-148 (1991).
9. G. Blume, G. Cevc, D. J. A. Crommelin, I. A. Bakker-Woudenberg, C. Kluft, and G. Storm. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. Biochim. Biophys. Acta 1149:180-184 (1993).
10. G. Haran, R. Cohen, L. K. Bar, and Y. Barenholz. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta 1151:201-215 (1993).
11. N. Emanuel, E. Kedar, E. M. Bolotin, N. I. Smorodinsky, and Y. Barenholz. Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: Pharmacokinetics and biodistribution in tumor-bearing mice. Submitted for publication.
12. Y. Barenholz, and S. Amselem. Quality control assays in the development and clinical use of liposome-based formulations. In: Gregoriadis, G., ed., Liposome Technology, 2nd ed., Vol. I, CRC Press, Boca Raton, FL, 1993, pp. 527-616.
13. A. B. Langer, N. Emanuel, J. Even, W. H. Fridman, O. Gohar, B. Gonen, B. Z. Katz, M. Ran, N. I. Smorodinksy, and I. F. Witz. Phenotypic properties of 3T3 cells transformed in vitro with polyoma virus and passaged once in syngeneic animals. Immunobiology 185:281-291 (1992).
14. L. Hudson and F. C. Hay. Practical Immunology, 3rd ed., Blackwell, Oxford, 1989, pp. 316-319.
15. E. M. Bolotin, R. Cohen, L. K. Bar, N. Emanuel, S. Ninio, D. D. Lasic, and Y. Barenholz. Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes. J. Liposome Res. 4:455-479 (1994).
16. N. Emanuel, E. Kedar, O. Toker, E. Bolotin, and Y. Barenholz. Steric stabilization of liposomes improves their use in diagnostics. In: Lasic, D. D. and Barenholz, Y., eds., Handbook on Nonmedical Applications of Liposomes, Vol. IV, CRC Press, Boca Raton, FL, pp. 229-243 (1996).
17. F. J. Martin, T. D. Heath, and R. R. C. New. Covalent attachment of proteins to liposomes. In: New, R.R.C., ed., Liposomes - A Practical Approach, IRL Press, Oxford, 1990, pp. 163-182.
18. D. Goren, A. Gabizon, and Y. Barenholz. The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior. Biochim. Biophys. Acta 1029:285-294 (1990).
19. L. S. Minamide and J. R. Bamburg. A filter paper dye-binding assay for quantitative determination of protein without interference from reducing agents or detergents. Anal. Biochem. 190:66-70 (1990).
20. J. Cummings and C. S. McArdle. Studies on the in vivo disposition of adriamycin in human tumors which exhibit different responses to the drug. Br. J. Cancer 53:835-838 (1986).
21. L. Wish, J. Furth, and R. H. Storey. Direct determination of plasma, cell and organ-blood volumes in normal and hyperemic mice. Proc. Soc. Exp. Biol. Med. 74:644-648 (1950).
22. S. Matzku, H. Krempel, H.-P. Weckenmann, V. Schirrmacher, H. Sinn, and H. Stricker. Tumour targeting with antibody-coupled liposomes: failure to achieve accumulation in xenografts and spontaneous liver metastases. Cancer Immunol. Immunother. 31:285-291 (1990).
23. P. A. M. Peeters, C. Oussoren, W. M. C. Eling, and D. J. A. Crommelin. Unwanted interactions of maleimidophenylbutyrate-phosphatidylethanolamine containing (immuno) liposomes with cells in vitro. J. Liposome Res. 1:261-268 (1990).
24. N. C. Phillips and A. Emili. Immunogenicity of immunoliposomes. Immunol. Lett. 30:291-296 (1991).
25. S. Hashida, I. Masayoshi, S. Inoue, K.-H. Ruan, and E. Ishikawa. More useful maleimide compounds for the conjugation of Fab' to horseradish peroxidase through thiol groups in the hinge. J. Appl. Biochem. 6:56-63 (1984).
26. R) liposomes. J. Liposome Res. 4:1-25, 1994.
27. T. D. Madden, P. R. Harrigan, L. C. Tai, M. B. Bally, L. D. Mayer, T. E. Redelmeier, H. C. Loughrey, C. P. Tilcock, L. W. Reinish, and P. R. Cullis. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem. Phys. Lipids 53:37-46 (1990).
28. R. Bredehorst, F. S. Ligler, A. W. Kusterbeck, E. L. Chang, B. P. Gaber, and C.-W. Vogel. Effect of covalent attachment of immunoglobulin fragments on liposomal integrity. Biochemistry 25:5693-5698 (1986).
29. I. Ahmad and T. M. Allen. Antibody-mediated specific binding and cytotoxicity of liposome-entrapped doxorubicin to lung cancer cells in vitro. Cancer Res. 52:4817-4820 (1992).